nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.163	0.279	CbGbCtD
Naltrexone—ABCB1—Betamethasone—ankylosing spondylitis	0.106	0.182	CbGbCtD
Naltrexone—ABCB1—Prednisolone—ankylosing spondylitis	0.104	0.179	CbGbCtD
Naltrexone—ABCB1—Prednisone—ankylosing spondylitis	0.0987	0.169	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—ankylosing spondylitis	0.0616	0.106	CbGbCtD
Naltrexone—ABCB1—Methotrexate—ankylosing spondylitis	0.0495	0.0849	CbGbCtD
Naltrexone—Naloxone—TLR4—ankylosing spondylitis	0.0168	1	CrCbGaD
Naltrexone—Depression—Methotrexate—ankylosing spondylitis	0.00063	0.00158	CcSEcCtD
Naltrexone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00063	0.00157	CcSEcCtD
Naltrexone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00063	0.00157	CcSEcCtD
Naltrexone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000629	0.00157	CcSEcCtD
Naltrexone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000628	0.00157	CcSEcCtD
Naltrexone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000623	0.00156	CcSEcCtD
Naltrexone—Angioedema—Dexamethasone—ankylosing spondylitis	0.00062	0.00155	CcSEcCtD
Naltrexone—Angioedema—Betamethasone—ankylosing spondylitis	0.00062	0.00155	CcSEcCtD
Naltrexone—Angiopathy—Prednisone—ankylosing spondylitis	0.000616	0.00154	CcSEcCtD
Naltrexone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000614	0.00154	CcSEcCtD
Naltrexone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000614	0.00153	CcSEcCtD
Naltrexone—Immune system disorder—Prednisone—ankylosing spondylitis	0.000613	0.00153	CcSEcCtD
Naltrexone—Malaise—Dexamethasone—ankylosing spondylitis	0.000612	0.00153	CcSEcCtD
Naltrexone—Malaise—Betamethasone—ankylosing spondylitis	0.000612	0.00153	CcSEcCtD
Naltrexone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00061	0.00153	CcSEcCtD
Naltrexone—Oedema—Triamcinolone—ankylosing spondylitis	0.00061	0.00153	CcSEcCtD
Naltrexone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000609	0.00152	CcSEcCtD
Naltrexone—Syncope—Dexamethasone—ankylosing spondylitis	0.000609	0.00152	CcSEcCtD
Naltrexone—Syncope—Betamethasone—ankylosing spondylitis	0.000609	0.00152	CcSEcCtD
Naltrexone—Infection—Triamcinolone—ankylosing spondylitis	0.000606	0.00152	CcSEcCtD
Naltrexone—Infection—Methylprednisolone—ankylosing spondylitis	0.000605	0.00151	CcSEcCtD
Naltrexone—Shock—Triamcinolone—ankylosing spondylitis	0.000601	0.0015	CcSEcCtD
Naltrexone—Insomnia—Prednisolone—ankylosing spondylitis	0.0006	0.0015	CcSEcCtD
Naltrexone—Alopecia—Prednisone—ankylosing spondylitis	0.0006	0.0015	CcSEcCtD
Naltrexone—Shock—Methylprednisolone—ankylosing spondylitis	0.000599	0.0015	CcSEcCtD
Naltrexone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000598	0.00149	CcSEcCtD
Naltrexone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000597	0.00149	CcSEcCtD
Naltrexone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000597	0.00149	CcSEcCtD
Naltrexone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000597	0.00149	CcSEcCtD
Naltrexone—Epistaxis—Methotrexate—ankylosing spondylitis	0.000596	0.00149	CcSEcCtD
Naltrexone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000596	0.00149	CcSEcCtD
Naltrexone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000596	0.00149	CcSEcCtD
Naltrexone—Mental disorder—Prednisone—ankylosing spondylitis	0.000595	0.00149	CcSEcCtD
Naltrexone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000594	0.00149	CcSEcCtD
Naltrexone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000592	0.00148	CcSEcCtD
Naltrexone—Malnutrition—Prednisone—ankylosing spondylitis	0.000591	0.00148	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00059	0.00147	CcSEcCtD
Naltrexone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000589	0.00147	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000588	0.00147	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—ankylosing spondylitis	0.000588	0.00147	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—ankylosing spondylitis	0.000586	0.00146	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000586	0.00146	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000578	0.00144	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—ankylosing spondylitis	0.000578	0.00144	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—ankylosing spondylitis	0.000576	0.00144	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000576	0.00144	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000571	0.00143	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—ankylosing spondylitis	0.000571	0.00143	CcSEcCtD
Naltrexone—Pain—Prednisolone—ankylosing spondylitis	0.000568	0.00142	CcSEcCtD
Naltrexone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000567	0.00142	CcSEcCtD
Naltrexone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000563	0.00141	CcSEcCtD
Naltrexone—Vision blurred—Prednisone—ankylosing spondylitis	0.000557	0.00139	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000556	0.00139	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000555	0.00139	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000554	0.00138	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000554	0.00138	CcSEcCtD
Naltrexone—Oedema—Betamethasone—ankylosing spondylitis	0.000554	0.00138	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—ankylosing spondylitis	0.000554	0.00138	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000552	0.00138	CcSEcCtD
Naltrexone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000551	0.00138	CcSEcCtD
Naltrexone—Infection—Betamethasone—ankylosing spondylitis	0.00055	0.00138	CcSEcCtD
Naltrexone—Infection—Dexamethasone—ankylosing spondylitis	0.00055	0.00138	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000548	0.00137	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000548	0.00137	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000547	0.00137	CcSEcCtD
Naltrexone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000547	0.00137	CcSEcCtD
Naltrexone—Shock—Betamethasone—ankylosing spondylitis	0.000545	0.00136	CcSEcCtD
Naltrexone—Shock—Dexamethasone—ankylosing spondylitis	0.000545	0.00136	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000544	0.00136	CcSEcCtD
Naltrexone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000543	0.00136	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000543	0.00136	CcSEcCtD
Naltrexone—Agitation—Prednisone—ankylosing spondylitis	0.000543	0.00136	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000541	0.00135	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000541	0.00135	CcSEcCtD
Naltrexone—Angioedema—Prednisone—ankylosing spondylitis	0.00054	0.00135	CcSEcCtD
Naltrexone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000535	0.00134	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000535	0.00134	CcSEcCtD
Naltrexone—Malaise—Prednisone—ankylosing spondylitis	0.000533	0.00133	CcSEcCtD
Naltrexone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00053	0.00133	CcSEcCtD
Naltrexone—Syncope—Prednisone—ankylosing spondylitis	0.00053	0.00132	CcSEcCtD
Naltrexone—Tinnitus—Methotrexate—ankylosing spondylitis	0.000529	0.00132	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000528	0.00132	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—ankylosing spondylitis	0.000528	0.00132	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—ankylosing spondylitis	0.000527	0.00132	CcSEcCtD
Naltrexone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000527	0.00132	CcSEcCtD
Naltrexone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000526	0.00132	CcSEcCtD
Naltrexone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000525	0.00131	CcSEcCtD
Naltrexone—Pain—Triamcinolone—ankylosing spondylitis	0.000522	0.0013	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000519	0.0013	CcSEcCtD
Naltrexone—Angiopathy—Methotrexate—ankylosing spondylitis	0.000515	0.00129	CcSEcCtD
Naltrexone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000513	0.00128	CcSEcCtD
Naltrexone—Convulsion—Prednisone—ankylosing spondylitis	0.000512	0.00128	CcSEcCtD
Naltrexone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000511	0.00128	CcSEcCtD
Naltrexone—Hypertension—Prednisone—ankylosing spondylitis	0.00051	0.00128	CcSEcCtD
Naltrexone—Chills—Methotrexate—ankylosing spondylitis	0.000509	0.00127	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000505	0.00126	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000505	0.00126	CcSEcCtD
Naltrexone—Myalgia—Prednisone—ankylosing spondylitis	0.000503	0.00126	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—ankylosing spondylitis	0.000503	0.00126	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000503	0.00126	CcSEcCtD
Naltrexone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000502	0.00125	CcSEcCtD
Naltrexone—Anxiety—Prednisone—ankylosing spondylitis	0.000501	0.00125	CcSEcCtD
Naltrexone—Alopecia—Methotrexate—ankylosing spondylitis	0.000501	0.00125	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—ankylosing spondylitis	0.000501	0.00125	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000501	0.00125	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0005	0.00125	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000498	0.00124	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000497	0.00124	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000497	0.00124	CcSEcCtD
Naltrexone—Discomfort—Prednisone—ankylosing spondylitis	0.000497	0.00124	CcSEcCtD
Naltrexone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000497	0.00124	CcSEcCtD
Naltrexone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000494	0.00123	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000489	0.00122	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000485	0.00121	CcSEcCtD
Naltrexone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000484	0.00121	CcSEcCtD
Naltrexone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000484	0.00121	CcSEcCtD
Naltrexone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000483	0.00121	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000482	0.00121	CcSEcCtD
Naltrexone—Oedema—Prednisone—ankylosing spondylitis	0.000482	0.00121	CcSEcCtD
Naltrexone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000482	0.0012	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000482	0.0012	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000482	0.0012	CcSEcCtD
Naltrexone—Infection—Prednisone—ankylosing spondylitis	0.000479	0.0012	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000478	0.0012	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000478	0.0012	CcSEcCtD
Naltrexone—Back pain—Methotrexate—ankylosing spondylitis	0.000478	0.00119	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—ankylosing spondylitis	0.000478	0.00119	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000478	0.00119	CcSEcCtD
Naltrexone—Shock—Prednisone—ankylosing spondylitis	0.000475	0.00119	CcSEcCtD
Naltrexone—Pain—Betamethasone—ankylosing spondylitis	0.000474	0.00118	CcSEcCtD
Naltrexone—Pain—Dexamethasone—ankylosing spondylitis	0.000474	0.00118	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000473	0.00118	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—ankylosing spondylitis	0.000471	0.00118	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—ankylosing spondylitis	0.000469	0.00117	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000466	0.00117	CcSEcCtD
Naltrexone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000466	0.00116	CcSEcCtD
Naltrexone—Anorexia—Prednisone—ankylosing spondylitis	0.00046	0.00115	CcSEcCtD
Naltrexone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000458	0.00115	CcSEcCtD
Naltrexone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000456	0.00114	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000456	0.00114	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000453	0.00113	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000453	0.00113	CcSEcCtD
Naltrexone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00045	0.00112	CcSEcCtD
Naltrexone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000449	0.00112	CcSEcCtD
Naltrexone—Malaise—Methotrexate—ankylosing spondylitis	0.000445	0.00111	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—ankylosing spondylitis	0.00044	0.0011	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—ankylosing spondylitis	0.00044	0.0011	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000439	0.0011	CcSEcCtD
Naltrexone—Dizziness—Prednisolone—ankylosing spondylitis	0.000439	0.0011	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000438	0.00109	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000438	0.00109	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000438	0.00109	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000438	0.00109	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000438	0.00109	CcSEcCtD
Naltrexone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000437	0.00109	CcSEcCtD
Naltrexone—Insomnia—Prednisone—ankylosing spondylitis	0.000436	0.00109	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000433	0.00108	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000432	0.00108	CcSEcCtD
Naltrexone—Cough—Methotrexate—ankylosing spondylitis	0.000431	0.00108	CcSEcCtD
Naltrexone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000431	0.00108	CcSEcCtD
Naltrexone—Convulsion—Methotrexate—ankylosing spondylitis	0.000428	0.00107	CcSEcCtD
Naltrexone—Myalgia—Methotrexate—ankylosing spondylitis	0.000421	0.00105	CcSEcCtD
Naltrexone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000421	0.00105	CcSEcCtD
Naltrexone—Chest pain—Methotrexate—ankylosing spondylitis	0.000421	0.00105	CcSEcCtD
Naltrexone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000419	0.00105	CcSEcCtD
Naltrexone—Rash—Prednisolone—ankylosing spondylitis	0.000419	0.00105	CcSEcCtD
Naltrexone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000418	0.00105	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000418	0.00104	CcSEcCtD
Naltrexone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000417	0.00104	CcSEcCtD
Naltrexone—Fatigue—Prednisone—ankylosing spondylitis	0.000416	0.00104	CcSEcCtD
Naltrexone—Headache—Prednisolone—ankylosing spondylitis	0.000416	0.00104	CcSEcCtD
Naltrexone—Discomfort—Methotrexate—ankylosing spondylitis	0.000416	0.00104	CcSEcCtD
Naltrexone—Constipation—Prednisone—ankylosing spondylitis	0.000413	0.00103	CcSEcCtD
Naltrexone—Confusional state—Methotrexate—ankylosing spondylitis	0.000406	0.00102	CcSEcCtD
Naltrexone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000404	0.00101	CcSEcCtD
Naltrexone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000403	0.00101	CcSEcCtD
Naltrexone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000403	0.00101	CcSEcCtD
Naltrexone—Infection—Methotrexate—ankylosing spondylitis	0.000401	0.001	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000398	0.000993	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000397	0.000993	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—ankylosing spondylitis	0.000397	0.000993	CcSEcCtD
Naltrexone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000395	0.000988	CcSEcCtD
Naltrexone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000394	0.000986	CcSEcCtD
Naltrexone—Nausea—Prednisolone—ankylosing spondylitis	0.000394	0.000985	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000392	0.000979	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—ankylosing spondylitis	0.000392	0.000979	CcSEcCtD
Naltrexone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000392	0.000979	CcSEcCtD
Naltrexone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00039	0.000974	CcSEcCtD
Naltrexone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000388	0.00097	CcSEcCtD
Naltrexone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000387	0.000968	CcSEcCtD
Naltrexone—Rash—Triamcinolone—ankylosing spondylitis	0.000385	0.000962	CcSEcCtD
Naltrexone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000385	0.000961	CcSEcCtD
Naltrexone—Anorexia—Methotrexate—ankylosing spondylitis	0.000384	0.00096	CcSEcCtD
Naltrexone—Rash—Methylprednisolone—ankylosing spondylitis	0.000384	0.00096	CcSEcCtD
Naltrexone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000384	0.000959	CcSEcCtD
Naltrexone—Urticaria—Prednisone—ankylosing spondylitis	0.000383	0.000958	CcSEcCtD
Naltrexone—Headache—Triamcinolone—ankylosing spondylitis	0.000382	0.000956	CcSEcCtD
Naltrexone—Headache—Methylprednisolone—ankylosing spondylitis	0.000382	0.000954	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000381	0.000953	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000381	0.000953	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000379	0.000947	CcSEcCtD
Naltrexone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000379	0.000947	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000367	0.000918	CcSEcCtD
Naltrexone—Dizziness—Betamethasone—ankylosing spondylitis	0.000366	0.000915	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000366	0.000915	CcSEcCtD
Naltrexone—Insomnia—Methotrexate—ankylosing spondylitis	0.000365	0.000911	CcSEcCtD
Naltrexone—Nausea—Triamcinolone—ankylosing spondylitis	0.000363	0.000906	CcSEcCtD
Naltrexone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000362	0.000905	CcSEcCtD
Naltrexone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000362	0.000904	CcSEcCtD
Naltrexone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000359	0.000898	CcSEcCtD
Naltrexone—Somnolence—Methotrexate—ankylosing spondylitis	0.000358	0.000896	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000355	0.000888	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—ankylosing spondylitis	0.000352	0.00088	CcSEcCtD
Naltrexone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000352	0.00088	CcSEcCtD
Naltrexone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00035	0.000876	CcSEcCtD
Naltrexone—Rash—Betamethasone—ankylosing spondylitis	0.000349	0.000873	CcSEcCtD
Naltrexone—Rash—Dexamethasone—ankylosing spondylitis	0.000349	0.000873	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000349	0.000872	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000349	0.000872	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000348	0.00087	CcSEcCtD
Naltrexone—Fatigue—Methotrexate—ankylosing spondylitis	0.000348	0.000869	CcSEcCtD
Naltrexone—Headache—Dexamethasone—ankylosing spondylitis	0.000347	0.000867	CcSEcCtD
Naltrexone—Headache—Betamethasone—ankylosing spondylitis	0.000347	0.000867	CcSEcCtD
Naltrexone—Asthenia—Prednisone—ankylosing spondylitis	0.000346	0.000865	CcSEcCtD
Naltrexone—Pain—Methotrexate—ankylosing spondylitis	0.000345	0.000862	CcSEcCtD
Naltrexone—Pruritus—Prednisone—ankylosing spondylitis	0.000341	0.000853	CcSEcCtD
Naltrexone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000332	0.00083	CcSEcCtD
Naltrexone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00033	0.000825	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00033	0.000824	CcSEcCtD
Naltrexone—Nausea—Dexamethasone—ankylosing spondylitis	0.000329	0.000822	CcSEcCtD
Naltrexone—Nausea—Betamethasone—ankylosing spondylitis	0.000329	0.000822	CcSEcCtD
Naltrexone—Urticaria—Methotrexate—ankylosing spondylitis	0.00032	0.0008	CcSEcCtD
Naltrexone—Dizziness—Prednisone—ankylosing spondylitis	0.000319	0.000797	CcSEcCtD
Naltrexone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000319	0.000796	CcSEcCtD
Naltrexone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000319	0.000796	CcSEcCtD
Naltrexone—Vomiting—Prednisone—ankylosing spondylitis	0.000307	0.000767	CcSEcCtD
Naltrexone—Rash—Prednisone—ankylosing spondylitis	0.000304	0.00076	CcSEcCtD
Naltrexone—Dermatitis—Prednisone—ankylosing spondylitis	0.000304	0.000759	CcSEcCtD
Naltrexone—Headache—Prednisone—ankylosing spondylitis	0.000302	0.000755	CcSEcCtD
Naltrexone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000297	0.000742	CcSEcCtD
Naltrexone—Asthenia—Methotrexate—ankylosing spondylitis	0.000289	0.000723	CcSEcCtD
Naltrexone—Nausea—Prednisone—ankylosing spondylitis	0.000287	0.000716	CcSEcCtD
Naltrexone—Pruritus—Methotrexate—ankylosing spondylitis	0.000285	0.000713	CcSEcCtD
Naltrexone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000276	0.000689	CcSEcCtD
Naltrexone—Dizziness—Methotrexate—ankylosing spondylitis	0.000267	0.000666	CcSEcCtD
Naltrexone—Vomiting—Methotrexate—ankylosing spondylitis	0.000256	0.000641	CcSEcCtD
Naltrexone—Rash—Methotrexate—ankylosing spondylitis	0.000254	0.000635	CcSEcCtD
Naltrexone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000254	0.000635	CcSEcCtD
Naltrexone—Headache—Methotrexate—ankylosing spondylitis	0.000253	0.000631	CcSEcCtD
Naltrexone—Nausea—Methotrexate—ankylosing spondylitis	0.000239	0.000598	CcSEcCtD
